ArticleJournal of thoracic disease2025
Global trends in the burden of tracheal, bronchus, and lung cancer attributable to household air pollution.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tracheal, bronchial, and lung (TBL) cancers, largely attributable to household air pollution (HAP), remain a critical public health challenge, particularly in low- and middle-income countries (LMICs). Using data from the Global Burden of Disease (GBD) 2021, this study evaluates global trends in HAP-related TBL cancer burden from 1990 to 2021 and projects future trends to 2051. Methods: The study extracted data on deaths and disability-adjusted life years (DALYs) from the GBD 2021 and assessed the burden of TBL cancer attributable to HAP by sex, age, region, and socio-demographic index (SDI). The age-period-cohort (APC) model examined the independent effects of age, period, and cohort, while the Bayesian age-period-cohort (BAPC) model predicted future trends over the next 30 years. Results: Between 1990 and 2021, deaths and DALYs from TBL cancer due to HAP decreased by 39.2% and 44.1%, respectively, with the largest declines in high SDI regions, while rates increased in Oceania and sub-Saharan Africa. The global age-standardized mortality rate (ASMR) peaked in the 85-89 years age group, and the age-standardized disability rate (ASDR) peaked in the 70-74 years age group. Males experienced a higher burden than females, with significant differences observed across SDI regions. Projections suggest that mortality and DALYs rates will rise over the next 30 years, with a higher burden forecast for females. Conclusions: Despite significant reductions, TBL cancer from HAP remains a major issue in low SDI regions, particularly in China. Projections indicate increasing mortality and DALYs rates over the next 30 years, disproportionately affecting women, highlighting the urgent need for targeted policies to reduce HAP exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.